Disciplinary Forum, Project Areas C and Z, Winter Semester 2015/16
Topic: "PSORIASIS and ATOPIC DERMATITIS – CLASSICAL and NEW THERAPEUTIC APPROACHES: What has to be considered in basic research?"
Organisation: Dr. Fiorenza Rancan (TP C04) and Dr. Lars Mundhenk (TP C03)
Date: Thursday, January 28, 2016
Time: 9:00am -2:00pm (0,5 CP)
Location: Charité – Universitätsmedizin Berlin, Department of Dermatology and Allergy, Luisenstr. 2, 10117 Berlin, library on the 2nd floor
Language: Englisch
Participation and Registration: for SFB 1112 members only; please register in advance with Jeannette Getzin / jeannette.getzin (at) fu-berlin.de
Program:
|
9:00 – 10:30 |
Reports from the Bench |
|
|
10 min. |
Hausmann, Christian |
C02 |
|
10 min. |
Hönzke, Stefan |
C02 |
|
10 min. |
Pischon, Hannah |
C03 |
|
10 min. |
Radbruch, Moritz |
C03 |
|
10 min. |
Frombach, Janna |
C04 |
|
10 min. |
Jung, Dr., Sora |
C05 |
|
10 min. |
Edlich, Alexander |
Z01 |
|
10 min. |
Gerecke, Dr., Christian |
Z01 |
|
10 min. |
Neumann, Falko |
Z01 |
|
10:30 - 11:00 |
COFFEE BREAK |
|
|
11:00 - 12:45 |
PSORIASIS and ATOPIC DERMATITIS - NEW THERAPEUTIC APPROACHES: What has to be considered in basic research? |
|
|
15 min.
|
Introduction: F. Rancan: Nucleic acids for the treatment of skin diseases |
|
|
15 min.
|
Introduction: L. Mundhenk: Antibodies targeting IL-17A, IL-22 and the IL-4 receptor |
|
|
1h 15 min. |
Group Work: A) Suitable Analytic Methods for New Biopharmaceuticals |
|
|
Group Work: B) Suitable in vitro Models for New Biopharmaceuticals |
|
|
|
Group Work: C) Suitable in vivo Models for New Biopharmaceuticals |
|
|
|
Group Work: D) Suitable Toxicity Tests for New Biopharmaceutical-Nanocarriers |
|
|
|
12:45 - 13:00 |
COFFEE REFILL |
|
|
13:00-14:00 |
Presentation of the Group Work and Discussion |
|